Metabolic-Fit / 100
MEDVi review
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
A fast-growing compounded GLP-1 program priced at $179 for the first month of semaglutide and $299 a month after, with the visit and medication included. It doesn't publish a tirzepatide price or a state list, keeps refunds narrow with a 72-hour cancellation window, and received an FDA warning letter in February 2026 over its labels and 'same active ingredient' claims.
then $299/mo ongoing
- Confirm HSA / FSA coverage
- Public information reviewed
- Confirm your total cost
MEDVi at a glance
- Semaglutide
- $299/mo compounded injection after the first month
- Tirzepatide
- Not published before intake
- Coverage
- Not published (state list available from support)
- Brand-name
- Yes
How we scored MEDVi
Every factor comes from MEDVi's own published pricing, disclosures and oversight, and the six combine into the 52/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the best on our list — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we checked this review
MEDVi's compounded semaglutide starts at $179 for the first month and then $299 a month, with the visit and medication included. It does not publish a tirzepatide price or its state list, brand-name options add a $99 membership to an unlisted drug cost, and it received an FDA warning letter in February 2026.
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $179 → $299 | InjectionMEDVi's FAQ: the semaglutide program starts at $179 for the first month, and refills are 'locked in at $299'. Physician review, plan, guidance and medication included. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what MEDVi's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- One all-in semaglutide price with the visit and medication included, and no membership fee
- Compounded tablets and brand-name options, including the Wegovy pill, alongside injections
- 24/7 support and care coaching
- Free shipping
The caveats
- FDA warning letter 721455, dated February 20, 2026, to MEDVi, LLC dba MEDVi, over labels implying it compounds the drugs and 'same active ingredient' claims
- The $179 is the first month only; refills are $299 a month
- No tirzepatide price and no state list published
- Brand-name options add a $99 membership to a drug cost that isn't listed
- No refund for the current or past months on a monthly plan, and cancellation needs 72 hours' notice
- No pregnancy, breastfeeding or PCOS guidance
A low first month, then the real rate
MEDVi sells compounded GLP-1s with one all-in price and no membership fee, and its headline is "start for just $179". Its own FAQ explains what that number is: the first month of the semaglutide program, covering the physician review, a personalized plan, 1:1 guidance and the medication shipped to your door. After that, refills are $299 a month. Budget around the $299. A year at that rate is about $3,600 before the first-month discount.
- Compounded semaglutide injection: $179 the first month, then $299 a month
- Compounded GLP-1 tablets: from $249, once-daily and dissolvable
- Wegovy pill, Wegovy injection or Zepbound: a $99 membership plus the medication, which is not priced on the page
- Compounded tirzepatide: no price published
So tirzepatide is on the menu as brand-name Zepbound, but you can't see what it will cost before the intake. If insulin resistance or PCOS makes tirzepatide the drug you are most likely to need, ask for that figure first.
Leaving is the part to read twice
MEDVi's cancellation policy asks for 72 hours' notice before your next billing date, by email or the portal chat; miss it and the next month is charged. On a monthly plan, it does not refund the month you cancel in or any earlier month. A full refund happens only if you cancel within 72 hours of starting and before receiving any service, or if a provider finds you ineligible. For a mother whose plans can change with one positive pregnancy test, set a reminder well before each renewal date.
What you won't find on its pages
MEDVi's terms say it serves "certain states" and that the list comes from customer service, so ask before you begin. Its pages say nothing about pregnancy, breastfeeding or PCOS. The baseline comes from the labels. For the injectables, discuss breastfeeding benefits and treatment risks with your clinician using the exact product label; compounded versions have no label of their own. For GLP-1 pills, including the Wegovy pill, breastfeeding is not recommended. Our breastfeeding guide explains the evidence. Clinical care comes through OpenLoop Health's network of US-licensed doctors, and support is available around the clock.
The FDA letter
On February 20, 2026, the FDA sent warning letter 721455 to MEDVi, LLC. The agency objected to product labels showing the MEDVi name, which suggested MEDVi compounds the drugs when it does not, and to claims that its compounded medication had the "same active ingredient" as Wegovy, Ozempic, Mounjaro and Zepbound. It treated both as false or misleading for drugs the FDA has not approved. The letter concerns marketing, not a test of the medication.
The bottom line
MEDVi is a simple, all-in compounded semaglutide program at $299 a month after a cheaper first month, with an unpublished tirzepatide price, an unpublished state list and a strict refund policy. CoreAge Rx, a featured partner, is another compounded program to investigate. Its public starting figures do not establish your standing semaglutide or tirzepatide bill. Ask each service for the prescribed molecule, dose, supply duration and renewal total before deciding which offer you can budget for.
The bottom line for mothers
Best for: A mother who wants an all-in compounded semaglutide price with no membership and is comfortable with a $299 refill rate and strict refund terms.
Alternatives to MEDVi
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge Rx86
Metabolic-Fit / 100
CoreAge RxFeatured partnerCoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
- Visit Found Health74
Metabolic-Fit / 100
The most complete set of routes on our list — a real branded lane through insurance or LillyDirect, a compounded lane priced the same at every dose, and a non-GLP-1 generics lane — undercut by a three-day refund window and a complaint pattern that sits squarely on billing.
- Visit MEDGm42
Metabolic-Fit / 100
Four named pharmacies, a named prescribing partner and brand-name Wegovy, Zepbound and Ozempic alongside the compounded line — that is a fuller disclosure than most providers we review manage. Compounded GLP-1 injections start at $179 a month and daily dissolvable tablets at $249, and the price attaches to the form rather than the molecule: the product page never says whether you are getting semaglutide or tirzepatide, and the terms confirm both are in scope. Two things deserve a mother's attention before she enrolls. The brand products are priced as a membership plus an undisclosed medication cost, and that membership is quoted at two different figures on one page, $99 beside Zepbound and Wegovy and $171 beside Ozempic. And the terms state that if a provider decides a different molecule suits you better, staying enrolled is itself your consent to the switch and the charges continue. It also discloses, unusually plainly, that people shown in its advertising may be actors or artificial intelligence rather than clinicians.
Providers like MEDVi
Keep comparing MEDVi
Head-to-head & alternatives
Ranked boards
- Best GLP-1 for women
- Best GLP-1 for PCOS & insulin resistance
- Best GLP-1 for perimenopause
- Best GLP-1 while breastfeeding (safety-first)
- Cheapest GLP-1 programs
- Compounded tirzepatide providers
- Cheapest tirzepatide online
- Cheapest semaglutide online
- Where to get Zepbound online
- Semaglutide vs tirzepatide: which is right for you
Related reading for mothers
MEDVi, answered
- What does MEDVi cost?
- Compounded semaglutide injections are $179 for the first month and $299 a month after that, with the physician review, plan, guidance and medication included and no membership fee. Compounded tablets start at $249. Brand-name options (the Wegovy pill, Wegovy injection and Zepbound) cost a $99 membership plus the medication, which MEDVi doesn't price on the page. A tirzepatide price isn't published.
- How do I cancel MEDVi, and can I get a refund?
- Email support or use the portal chat at least 72 hours before your next billing date. On a monthly plan, MEDVi does not refund the month you cancel in or any earlier month. A full refund applies only if you cancel within 72 hours of starting and before receiving any service, or if a provider finds you ineligible.
- Is MEDVi available in my state?
- MEDVi's terms say it serves 'certain states' and that the current list comes from customer service. It isn't published, so ask before you start the intake.
- What was the FDA warning letter about?
- In February 2026 the FDA wrote to MEDVi, LLC about product labels showing 'MEDVi', which suggested MEDVi compounds the drugs, and about claims that its compounded medication had the 'same active ingredient' as Wegovy, Ozempic, Mounjaro and Zepbound. The FDA treated those as false or misleading for drugs it has not approved.
Pricing, states and verification reflect MEDVi's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.